Skip to Main Content

Author Details

Ronald Boellaard
Cancer Center Amsterdam, Vrije Universiteit Amsterdam
1996
499
71
PMIDPaper TitleJournal TitlePublished Year
36195742Manual Versus Artificial Intelligence-Based Segmentations as a Pre-processing Step in Whole-body PET Dosimetry Calculations.Mol Imaging Biol2023
37758869Sensitivity of an AI method for [<sup>18</sup>F]FDG PET/CT outcome prediction of diffuse large B-cell lymphoma patients to image reconstruction protocols.EJNMMI Res2023
37624384International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology.Eur J Nucl Med Mol Imaging2023
38067257<sup>89</sup>Zr-Immuno-PET with Immune Checkpoint Inhibitors: Measuring Target Engagement in Healthy Organs.Cancers (Basel)2023
37620051Ethical Considerations for Artificial Intelligence in Medical Imaging: Deployment and Governance.J Nucl Med2023
37552369Quantification of P-glycoprotein function at the human blood-brain barrier using [<sup>18</sup>F]MC225 and PET.Eur J Nucl Med Mol Imaging2023
37652540PET Imaging and Protein Expression of Prostate-Specific Membrane Antigen in Glioblastoma: A Multicenter Inventory Study.J Nucl Med2023
37889456Head-to-head comparison of relative cerebral blood flow derived from dynamic [<sup>18</sup>F]florbetapir and [<sup>18</sup>F]flortaucipir PET in subjects with subjective cognitive decline.EJNMMI Res2023
37943772Optimization and validation of 18F-DCFPyL PET radiomics-based machine learning models in intermediate- to high-risk primary prostate cancer.PLoS One2023
37536740Long Versus Short Axial Field of View Immuno-PET/CT: Semiquantitative Evaluation for <sup>89</sup>Zr-Trastuzumab.J Nucl Med2023
37722357Prognostic model using 18F-FDG PET radiomics predicts progression-free survival in relapsed/refractory Hodgkin lymphoma.Blood Adv2023
37493827Altered brain metabolism in frontotemporal dementia and psychiatric disorders: involvement of the anterior cingulate cortex.EJNMMI Res2023
37191489MRI Features for Identifying <i>MYCN</i>-amplified <i>RB1</i> Wild-type Retinoblastoma.Radiology2023
37250654Explainable artificial intelligence (XAI) in radiology and nuclear medicine: a literature review.Front Med (Lausanne)2023
36947185Optimisation of scan duration and image quality in oncological <sup>89</sup>Zr immunoPET imaging using the Biograph Vision PET/CT.Eur J Nucl Med Mol Imaging2023
37345017Development and External Validation of a PET Radiomic Model for Prognostication of Head and Neck Cancer.Cancers (Basel)2023
37180993Cognitive performance in multiple sclerosis: what is the role of the gamma-aminobutyric acid system?Brain Commun2023
37142345European Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations: molecular imaging and therapy in haematological tumours.Lancet Haematol2023
37399444Neurobiological basis and risk factors of persistent fatigue and concentration problems after COVID-19: study protocol for a prospective case-control study (VeCosCO).BMJ Open2023
37001036Baseline PET radiomics outperforms the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma.Blood2023
36820891Validation of simplified uptake measures against dynamic Patlak K<sub>i</sub> for quantification of lesional <sup>89</sup>Zr-Immuno-PET antibody uptake.Eur J Nucl Med Mol Imaging2023
36522184Artificial Intelligence in Nuclear Medicine: Opportunities, Challenges, and Responsibilities Toward a Trustworthy Ecosystem.J Nucl Med2023
36538846EFOMP's protocol quality controls in PET/CT and PET/MR.Phys Med2023
36933075A multi-label CNN model for the automatic detection and segmentation of gliomas using [<sup>18</sup>F]FET PET imaging.Eur J Nucl Med Mol Imaging2023
36735488[18F]FDG and [18F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant.Clin Cancer Res2023
36657208Magnetic resonance imaging based radiomics prediction of Human Papillomavirus infection status and overall survival in oropharyngeal squamous cell carcinoma.Oral Oncol2023
36071221Cerebral blood flow, amyloid burden, and cognition in cognitively normal individuals.Eur J Nucl Med Mol Imaging2023
36306337Baseline radiomics features and MYC rearrangement status predict progression in aggressive B-cell lymphoma.Blood Adv2023
36271598Precision estimates of relative and absolute cerebral blood flow in Alzheimer's disease and cognitively normal individuals.J Cereb Blood Flow Metab2023
36302172Meta-Analysis of the Test-Retest Repeatability of [18F]-Fluorodeoxyglucose Standardized Uptake Values: Implications for Assessment of Tumor Response.Clin Cancer Res2023
36166080Reproducibility of [18F]FDG PET/CT liver SUV as reference or normalisation factor.Eur J Nucl Med Mol Imaging2023
34272316Study of <sup>89</sup>Zr-Pembrolizumab PET/CT in Patients With Advanced-Stage Non-Small Cell Lung Cancer.J Nucl Med2022
358408172-[<sup>18</sup>F]-FDG PET for imaging brain involvement in patients with long COVID: perspective of the EANM Neuroimaging Committee.Eur J Nucl Med Mol Imaging2022
35737201Alzheimer's disease pattern derived from relative cerebral flow as an alternative for the metabolic pattern using SSM/PCA.EJNMMI Res2022
35708168Functional stress imaging to predict abnormal coronary fractional flow reserve: the PACIFIC 2 study.Eur Heart J2022
35598481Quality control in PET/CT and PET/MRI: Results of a survey amongst European countries.Phys Med2022
35626225Prediction of Non-Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients with <sup>18</sup>F-FDG PET Radiomics Based Machine Learning Classification.Diagnostics (Basel)2022
35362794First-time imaging of [<sup>89</sup>Zr]trastuzumab in breast cancer using a long axial field-of-view PET/CT scanner.Eur J Nucl Med Mol Imaging2022
35357901Proposed New Dynamic Prognostic Index for Diffuse Large B-Cell Lymphoma: International Metabolic Prognostic Index.J Clin Oncol2022
35618476Nuclear Medicine and Artificial Intelligence: Best Practices for Evaluation (the RELAINCE Guidelines).J Nucl Med2022
35512998<sup>89</sup>Zr-DFO-Durvalumab PET/CT Before Durvalumab Treatment in Patients with Recurrent or Metastatic Head and Neck Cancer.J Nucl Med2022
35904645Combatting the effect of image reconstruction settings on lymphoma [<sup>18</sup>F]FDG PET metabolic tumor volume assessment using various segmentation methods.EJNMMI Res2022
36308568Shortened duration whole body <sup>18</sup>F-FDG PET Patlak imaging on the Biograph Vision Quadra PET/CT using a population-averaged input function.EJNMMI Phys2022
36241696Prognostic value of TARC and quantitative PET parameters in relapsed or refractory Hodgkin lymphoma patients treated with brentuximab vedotin and DHAP.Leukemia2022
36065038Optimal imaging time points considering accuracy and precision of Patlak linearization for <sup>89</sup>Zr-immuno-PET: a simulation study.EJNMMI Res2022
35925442Comparing lesion and feature selections to predict progression in newly diagnosed DLBCL patients with FDG PET/CT radiomics features.Eur J Nucl Med Mol Imaging2022
36057616Longitudinal change in ATN biomarkers in cognitively normal individuals.Alzheimers Res Ther2022
36194301Standardised lesion segmentation for imaging biomarker quantitation: a consensus recommendation from ESR and EORTC.Insights Imaging2022
36089634External validation: a simulation study to compare cross-validation versus holdout or external testing to assess the performance of clinical prediction models using PET data from DLBCL patients.EJNMMI Res2022
36319985Prognostic value of combined MTV and ADC derived from baseline FDG PET/MRI in aggressive non-Hodgkins lymphoma.BMC Cancer2022
  • 1 - 50 of 499

Recommended Authors

Ashley Gillman
The Australian e-Health Research Centre
Career Start Year 2017
Number of shared co-authors 7
Randy Yeh
Department of Radiology Memorial Sloan Kettering Cancer Center
Career Start Year 2017
Number of shared co-authors 2
Udunna C Anazodo
Montreal Neurological Institute, McGill University
Career Start Year 2013
Number of shared co-authors 3
Joshua D Schaefferkoetter
Siemens Medical Solutions USA, Inc.
Career Start Year 2013
Number of shared co-authors 4
Yothin Rakvongthai
Chulalongkorn University
Career Start Year 2013
Number of shared co-authors 5
Jaewon Yang
University of California san francisco
Career Start Year 2012
Number of shared co-authors 3
Chuan Huang
The Renaissance School of Medicine at Stony Brook University
Career Start Year 2012
Number of shared co-authors 6
Milan Grkovski
Memorial Sloan Kettering Cancer Center
Career Start Year 2012
Number of shared co-authors 3
Vincent Dunet
Lausanne University Hospital and University of Lausanne
Career Start Year 2011
Number of shared co-authors 0
Xuezhu Zhang
College of Biomedical Engineering, University of California Davis
Career Start Year 2010
Number of shared co-authors 3
Raquel Perez-Lopez
Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus
Career Start Year 2010
Number of shared co-authors 1
Zhifang Wu
The First Hospital of Shanxi Medical University
Career Start Year 2009
Number of shared co-authors 1
Qingguo Xie
College of Life Science and Technology, Huazhong University of Science and Technology
Career Start Year 2009
Number of shared co-authors 1
Pedram Heidari
Massachusetts General Hospital
Career Start Year 2008
Number of shared co-authors 4
Ramesh Paudyal
Memorial Sloan Kettering Cancer Center
Career Start Year 2007
Number of shared co-authors 1
Youngho Seo
University of California san francisco
Career Start Year 2005
Number of shared co-authors 3
Guido Davidzon
Stanford University
Career Start Year 2005
Number of shared co-authors 0
Marc D Normandin
Massachusetts General Hospital, the Gordon Center for Medical Imaging
Career Start Year 2005
Number of shared co-authors 9
Li-Ping Fu
Peking University
Career Start Year 2002
Number of shared co-authors 1
Lance T Hall
University of Wisconsin Hospitals and Clinics
Career Start Year 1998
Number of shared co-authors 0
Amita Shukla-Dave
Memorial Sloan Kettering Cancer Center
Career Start Year 1997
Number of shared co-authors 1
Baixuan Xu
First Medical Center, Chinese PLA General Hospital
Career Start Year 1994
Number of shared co-authors 1
Frank P DiFilippo
Cleveland Clinic
Career Start Year 1992
Number of shared co-authors 3
Magnus Dahlbom
David Geffen School of Medicine, university of california los angeles
Career Start Year 1988
Number of shared co-authors 7
Curtis B Caldwell
Sunnybrook Research Institute
Career Start Year 1986
Number of shared co-authors 6
Javier E Villanueva-Meyer
University of California san francisco
Career Start Year 1986
Number of shared co-authors 9
John L Humm
Memorial Sloan Kettering Cancer Center
Career Start Year 1986
Number of shared co-authors 11
Daniel H S Silverman
University of California los angeles
Career Start Year 1985
Number of shared co-authors 5
Jiahe Tian
First Medical Center of Chinese PLA General Hospital
Career Start Year 1982
Number of shared co-authors 1
Henry Rusinek
NYU Grossman School of Medicine
Career Start Year 1978
Number of shared co-authors 5

Collaborators

Charles R Leemans
Location Vrije Universiteit Amsterdam
Co-authored papers 13
Ulrich D??hrsen
University Hospital Essen, University of Duisburg-Essen
Co-authored papers 10
Philippe Lambin
Maastricht University
Co-authored papers 9
Wouter van Elmpt
Maastricht University Medical Center+
Co-authored papers 8
Ir??ne Buvat
Institut Curie, PSL Research University, University Paris Saclay, Inserm LITO
Co-authored papers 7
Hugo J W L Aerts
Harvard Medical School
Co-authored papers 7
Richard L Wahl
Mallinckrodt Institute of Radiology, Washington University in St. Louis
Co-authored papers 7
John J Sunderland
University of Iowa
Co-authored papers 6
Arman Rahmim
BC Cancer Research Institute, University of British Columbia
Co-authored papers 6
Carolien P Schr??der
University of Groningen, University Medical Center Groningen
Co-authored papers 5
Ralph T H Leijenaar
Maastricht University Medical Center (MUMC+)
Co-authored papers 5
Andre Dekker
Maastricht University Medical Centre
Co-authored papers 4
Abhinav K Jha
Washington University in St. Louis
Co-authored papers 4
Sven Zuehlsdorff
Siemens Medical Solutions USA, Inc.
Co-authored papers 4
Babak Saboury
Clinical Center
Co-authored papers 4
Karl-Heinz Jöckel
Co-authored papers 4
Esther G C Troost
German Cancer Research Center (DKFZ)
Co-authored papers 4
Peter J H Scott
University of Michigan Medical School ann arbor
Co-authored papers 4
Joyita Dutta
University of Massachusetts Amherst
Co-authored papers 3
Patrick M M Bossuyt
University of Amsterdam
Co-authored papers 3
Henri J M M Mutsaerts
Vrije Universiteit Amsterdam
Co-authored papers 3
Danielle C Cath
Co-authored papers 3
Heiko Sch??der
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Mathieu Hatt
INSERM
Co-authored papers 3
Dirk De Ruysscher
Maastro Clinic
Co-authored papers 3
Robert B Innis
National Institute of Mental Health
Co-authored papers 3
Tyler J Bradshaw
University of Wisconsin-Madison
Co-authored papers 3
Ruud H Brakenhoff
Vrije Universiteit Amsterdam
Co-authored papers 2
Quanzheng Li
Massachusetts General Hospital
Co-authored papers 2
Mark A Mintun
Mallinckrodt Institute of Radiology , Washington University School of Medicine
Co-authored papers 2
Release 1.2